InMode Ltd. (INMD) is a Healthcare stock trading at $13.39 (as of 2026-06-18), with a market capitalization of $882.59M and a trailing P/E of 9.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
InMode Ltd. develops, manufactures, and markets aesthetic medical products, including minimally invasive devices that use its radiofrequency-assisted lipolysis and deep subdermal fractional radiofrequency technologies. Its product offerings cover procedures such as body and face contouring, skin rejuvenation, and certain women’s health indications, as well as non-invasive aesthetic treatments.